The “innovative drug concept” sparked enthusiasm, but its value quickly dropped after two consecutive price increases. Xiaofang Pharmaceutical’s main business remains the traditional OTC market.

Xiaofang Pharmaceutical achieved two consecutive price increases driven by the concept of innovative drugs, but its stock price quickly declined afterward. The company’s main business still focuses on OTC medicines, and no substantial progress has been made in its innovative drug business.